Related Experiment Videos
Pleural effusions: pathophysiology and management with intrapleural tetracycline
1School of Pharmacy, University of Kansas, Lawrence.
Drug Intelligence & Clinical Pharmacy
|January 1, 1988
Summary
Intrapleural tetracycline effectively manages recurrent pleural effusions by causing pleural membrane adhesion. This treatment is well-tolerated, offering a cost-effective and readily available option for patients experiencing chronic effusions.
Area of Science:
- Pulmonology
- Thoracic Medicine
Background:
- Chronic or recurrent pleural effusions cause significant patient discomfort.
- Previous management strategies, including surgical and pharmacological interventions, have shown moderate success.
- Understanding the pathophysiology of pleural effusion is crucial for effective management.
Purpose of the Study:
- To review the pathophysiology of pleural effusion.
- To evaluate the efficacy and safety of intrapleural tetracycline in managing recurrent pleural effusions.
- To provide guidelines for the preparation and administration of intrapleural tetracycline.
Main Methods:
- Review of existing animal and human studies on intrapleural tetracycline.
- Analysis of the mechanism of action, involving induction of pleural adhesion.
- Assessment of reported side effects and patient outcomes.
Main Results:
- Intrapleural tetracycline has demonstrated effectiveness in preventing pleural effusion recurrence.
- The treatment is associated with minor side effects, primarily fever and pleuritic pain.
- Animal and human studies confirm tetracycline's efficacy.
Conclusions:
- Intrapleural tetracycline is an effective agent for managing recurrent pleural effusions.
- Its low toxicity, ease of use, availability, and cost make it a strong first-line treatment option.
- Tetracycline offers a promising therapeutic strategy for pleural effusions.